Procter & Gamble (PG)

NYSE Consumer Staples Personal Care Products S&P 500Dow 30
$168.32
+2.92 (+1.77%)
Close of Nov 09, 2026 · end-of-day data

PG 8-K filings in 2025

Every material Form 8-K Procter & Gamble filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.

Briefs in 2025117 on record in all
Latest filing in 2025Dec 15, 2025leadership
High impact (4-5)0of 1 brief
ToneNeutral1
Dec 15, 9:15 AM ET

P&G executive Jennifer Davis to retire as Health Care CEO effective June 30, 2026

Neutral leadership Written later 5.02

Procter & Gamble said Jennifer Davis, its Chief Executive Officer - Health Care, notified the company on December 9, 2025 of her intent to retire effective June 30, 2026, after more than 33 years of service. The filing does not name a successor or describe any change to compensation, so shareholders should note a senior leadership transition in one of the company's business units.

  • Jennifer Davis, Chief Executive Officer - Health Care, notified P&G of her retirement on December 9, 2025
  • Retirement is effective June 30, 2026
  • Davis has more than 33 years of service with the company
  • The filing does not name a successor
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Procter & Gamble filing is on SEC EDGAR ↗. 8-K briefs of other companies →